The Native Antigen Company is part of LGC Clinical Diagnostics - Learn More

0 Items
Select Page

Get in touch with one of our experts

The Native Antigen Company offers custom contract services to develop panels of high quality influenza antigens using our proprietary VirtuE expression system, which ensures full glycosylation and proper folding. To support researchers working with specific and emerging strains of Influenza, we have demonstrated the ability of our expression system to successfully produce Haemagglutinin and Neuraminidase proteins from >90% of those attempted (shown right).

The availability of highly purified protein from the specific influenza strain that you are working with allows a detailed assessment of the immune responses, including vaccine-induced responses to a particular strain of interest. In addition to protein expression services, we also offer antibody generation and immunoassay development services to provide additional support for your influenza research.

For a bespoke proposal and consultation, please contact us using the form below.

Strain
Subtype
Influenza A/Brisbane/02/2018
H1N1
Influenza A/Kansas/14/2017
H3N2
Influenza A/Singapore/INFIMH-16-0019/2016
H3N2
Influenza A/California/07/2009
H1N1
Influenza A/Aichi/2/1968
H3N2
Influenza A/Wisconsin/67/2005
H3N2
Influenza A/Puerto Rico/8/1934
H1N1
Influenza A/Hong Kong/483/97
H5N1
Influenza A/Shanghai/2/2013
H7N9
Influenza A/Guinea fowl/Hong Kong/WF10/99
H9N2
Influenza B/Colorado/06/2017
N/A

Would you like to be kept informed of the latest news and innovations from the infectious disease community? Please let us know if you would like us to contact you or not by selecting one of the options below.

2 + 4 =